Indication

Vaccination to prevent genital warts due to human papillomavirus

Genital warts, or condylomata acuminata, are benign proliferative epithelial lesions caused by sexually transmitted infection with human papillomavirus, predominantly non-oncogenic low-risk genotypes HPV-6 and HPV-11. Read more about Vaccination to prevent genital warts due to human papillomavirus

5 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Vaccination to prevent genital warts due to human papillomavirus therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Vaccination to prevent genital warts due to human papillomavirus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Vaccination to prevent genital warts due to human papillomavirus.

Genital warts, or condylomata acuminata, are benign proliferative epithelial lesions caused by sexually transmitted infection with human papillomavirus, predominantly non-oncogenic low-risk genotypes HPV-6 and HPV-11.

The condition affects the integumentary and mucosal surfaces of the external genitalia, perineum, perianal region, and anal canal in sexually active male and female adolescents and adults.

Pathophysiologically, the virus infects basal keratinocytes through microscopic epithelial microtrauma, driving localized cellular proliferation and epidermal hyperplasia.

This process clinically manifests as painless, pruritic, flat, sessile, or exophytic cauliflower-like papules that can cause physical discomfort, bleeding, and psychological distress.

Personalize your experience

Follow Vaccination to prevent genital warts due to human papillomavirus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it